(Q43674942)

25 November 2017

0 references

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials (English)

1 reference

25 November 2017

1 reference

venous thromboembolism

1 reference

1

1 reference

25 November 2017

D J Quinlan

2

1 reference

25 November 2017

J D Douketis

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

358

1 reference

25 November 2017

issue

9275

1 reference

25 November 2017

page(s)

9-15

1 reference

Prevention of venous thromboembolism

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Evidence for the needs of out-of-hospital thrombosis prophylaxis: introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: the French study--venographic outcome at 35 days

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: the Swedish study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Prolonged prophylaxis with unfractioned heparin is effective to reduce delayed deep vein thrombosis in total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Summing up evidence: one answer is not always enough.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Why sources of heterogeneity in meta-analysis should be investigated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Prolonged prophylaxis after joint replacement: another step sideways?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Total hip replacements in the National Health Service: is need being met?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

Trends in the utilization of primary total hip arthroplasty, 1969 through 1990: a population-based study in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905249-1

7 January 2021

10.1016/S0140-6736(00)05249-1

Identifiers

DOI

1 reference

25 November 2017

1 reference